NCLAT stays eviction of Sterling Biotech from its premise
Besides, the appellate tribunal also said that "the Liquidator cannot sell the assets of the premises in question." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 4, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharma shuts 2 Gujarat R & D centres to cut costs
Sources said the company ’s R&D centre at Gurgaon (started by erstwhile Ranbaxy) will now undertake the clinical research handled by the Vadodara facility (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 3, 2019 Category: Pharmaceuticals Source Type: news

Mylan deal to give a boost to Pfizer ’s India business: Analysts
On Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 31, 2019 Category: Pharmaceuticals Source Type: news

Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-end
USFDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice deviations at DR Reddy's API manufacturing facilities at Srikakulam. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 30, 2019 Category: Pharmaceuticals Source Type: news

Strides inks JV pact with China's Sihuan Pharma
Sihuan will leverage its over 4,000 strong sales force and 3,000 plus distributors across Mainland China to market the products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2019 Category: Pharmaceuticals Source Type: news

Cipla seeks favourable policy for domestic pharma cos, ease of doing biz
Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a strong mandate, expectations are high. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 28, 2019 Category: Pharmaceuticals Source Type: news

Alkem Laboratories founder Samprada Singh passes away
Singh was a pharma industry veteran with over 43 years of experience in the Indian pharmaceutical industry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2019 Category: Pharmaceuticals Source Type: news

NCLAT stays sale of Orchid to Dhanuka
In response to a petition filed by Accord Life Spec Private Ltd, a company promoted by DMK MP Jagatrakshagan ’s family members, the NCLAT stayed the bids. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pakistan imports over $36 million worth of anti-rabies, anti-venom vaccines from India
Pakistan was buying the vaccines despite the chill in bilateral ties, especially after the Pulwama terror attack by a suicide bomber belonging to Pakistan-based Jaish-e-Mohammed terrorist. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2019 Category: Pharmaceuticals Source Type: news

Indoco Remedies gets EIR from USFDA for 2 plants in Goa
"We are happy to receive the EIR in less than two months from the date of inspection," Indoco Remedies MD Aditi Kare Panandikar said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2019 Category: Pharmaceuticals Source Type: news

Mega diabetes drug to be cheaper soon
With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2019 Category: Pharmaceuticals Source Type: news

Zydus Cadila launches insomnia drug in US market
Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets tentative nod from USFDA for glycemic control drug
Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending December 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2019 Category: Pharmaceuticals Source Type: news

Health Ministry proposes minimum standards for clinical establishments
Clinical Establishment (Registration and Regulation) Act, 2010, makes registration a must for running a clinical establishment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2019 Category: Pharmaceuticals Source Type: news

USFDA completes inspection of Strides Pharma Bengaluru plant
The company's facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic version of Allegra D in US
"We are pleased to be expanding our pseudoephedrine-based product offering in time for the cough, cold and allergy season," Dr Reddy's Senior VP says. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2019 Category: Pharmaceuticals Source Type: news

Cabinet okays Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities
Of the Rs 330.35 crore, Rs 158.35 crore will be utilised to clear unpaid salary and Rs 172 crore for meeting the VRS liability. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

NHA looks to make Ayushman Bharat more viable
The idea behind this policy is to lower purchase costs for hospitals, helping make the procedure rates sustainable. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

US FDA finds "significant violations" at India's Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

Cipla forms JV with Jiangsu Acebright for respiratory medicines in China
The agreement is between Chinese firm Jiangsu Acebright and Cipla's European arm, Cipla EU for a combined investment of USD 30 million, as per a company statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2019 Category: Pharmaceuticals Source Type: news

Lupin aims to launch new products across geographies this fiscal
"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market," company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2019 Category: Pharmaceuticals Source Type: news

USFDA found birds flying in warehouse, lack of toilet paper at United Breweries plant
The company is the leader in beer category in India with more than 50 per cent share of the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2019 Category: Pharmaceuticals Source Type: news

Bayer ’s move to block Natco’s colorectal cancer brand dismissed by Delhi HC
Bayer raised the objection against Natco ’s brand launched under the name Regonat alleging infringement of its patent rights. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2019 Category: Pharmaceuticals Source Type: news

Audit of Laurus Labs completed by USFDA without objections
The maiden United States Food and Drug Administration (USFDA) audit for Laurus Labs was successfully completed without Form 483 . (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2019 Category: Pharmaceuticals Source Type: news

Code prohibits doctors from taking gifts from pharmaceutical companies
Health Minister Harsh Vardhan said that the code of conduct for doctors in their relationship with pharmaceutical and allied sector industry prohibits them from taking gifts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues 5 observations to Dr Reddy's plant in Hyderabad
Dr.Reddy's Laboratories was issued a Form 483 which notifies the company's management of objectionable conditions, with 5 observations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2019 Category: Pharmaceuticals Source Type: news

Glenmark gets final nod from USFDA for angina treatment drug
The product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 9, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddys launches anti-phlegm OTC drug in US market
OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 9, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues 12 observations for 3 Biocon units in Malaysia
US health regulator has issued 12 observations after the inspection of three of Biocon's units in Malaysia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 8, 2019 Category: Pharmaceuticals Source Type: news

Price erosion symptoms: Dr Reddy's Laboratories plans to launch value-added drugs in US
Dr Reddy's Laboratories has said the company plans to launch several value-added products this fiscal tooffset the persisting problem. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2019 Category: Pharmaceuticals Source Type: news

Buyout giants in talks with Wockhardt for domestic formulations business
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 4, 2019 Category: Pharmaceuticals Source Type: news

Indian pharma industry to grow at 11-13 pc in FY2020: Icra
According to an Icra report covering a sample of 21 firms in the industry, the growth during FY2019 stood at around 12 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 4, 2019 Category: Pharmaceuticals Source Type: news

FDA pulls up Aurobindo Pharma for 'repeated' failures in CGMP
The FDA recently issued a letter warning the drug- makers unit X1 in Srikakulam district of Andhra Pradesh for deviations from CGMP for API. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 3, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for seizure treatment drug
The approved product is therapeutically equivalent to the reference listed drug Klonopin orally disintegrating tablets of Hoffmann-La Roche, Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2019 Category: Pharmaceuticals Source Type: news

Strides Pharma arm signs pacts for sale of Australian business to Arrow Pharma
The company said it expects the transaction to close on or around July 10, 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2019 Category: Pharmaceuticals Source Type: news

Novartis announces 26 week gender-neutral parental leave
The company believes this move will enrich the workplace and foster a more inclusive culture in the organisation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2019 Category: Pharmaceuticals Source Type: news

India asks its states not to partner with Philip Morris-funded foundation
India's federal health ministry has sent a letter, dated June 24, to chief secretaries of all states, saying they should not partner with Foundation for a Smoke-Free World. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 30, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharma arm enters pact with China Medical System
China Medical System will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, the terms of which are confidential, the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2019 Category: Pharmaceuticals Source Type: news

New cholera vaccine in clinical stage promises to end supply shortage
Cholera is an acute diarrheal infection caused by food or water carrying the vibrio cholerae bacteria. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2019 Category: Pharmaceuticals Source Type: news

GSK to fund doctoral programs at Regional Centre for Biotechnology
Students with a master ’s degree in biostatistics, maths, statistics and bioinformatics can apply, and will have to take an aptitude test and clear an interview. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 26, 2019 Category: Pharmaceuticals Source Type: news

NCLT approves Dhanuka Lab ’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma
A consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 26, 2019 Category: Pharmaceuticals Source Type: news

Novartis wins Gilenya reprieve as judge blocks generics, for now
The judge said letting generics makers sell their versions before the patent dispute was decided would damage the Swiss drugmaker more than those wanting a piece of Gilenya's market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 25, 2019 Category: Pharmaceuticals Source Type: news

Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals
"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capability," GSK Pharmaceuticals MD (India) A Vaidheesh told PTI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 23, 2019 Category: Pharmaceuticals Source Type: news

Glenmark Pharma says USFDA has issued CRL for Ryaltris
The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities, the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2019 Category: Pharmaceuticals Source Type: news

Advent International emerges sole bidder for Bharat Serums
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 21, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets warning letter from USFDA for Andhra Pradesh unit
The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 21, 2019 Category: Pharmaceuticals Source Type: news

Price of 1032 medicines capped by govt: Mansukhlal Mandavia
He said Jan Aushadhi stores are opened with an aim of providing quality and affordable medicines to the poor. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 21, 2019 Category: Pharmaceuticals Source Type: news

Fourth carcinogen discovered in heart pills used by millions
DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2019 Category: Pharmaceuticals Source Type: news

Indian Pharma industry aspiring to grow to $120-130 billion by 2030: IPA
The report is based on a research collaboration with McKinsey& Co and inputs from the IPA members and industry leaders, IPA said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2019 Category: Pharmaceuticals Source Type: news

USFDA for voluntary action by Cadila Healthcare on Ahmedabad SEZ facility
The plant has received an establishment inspection report (EIR). The EIR report stated that the classification of the facility is VAI, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 17, 2019 Category: Pharmaceuticals Source Type: news